Identification of Genes Involved in Juvenile Idiopathic Arthritis by Wholel Exome Sequencing

Study Overview
=================
Brief Summary
-----------------
Juvenile idiopathic arthritis (JIA) is considered to be a multifactorial disease caused by a combination of environmental factors and predisposing genetic factors. Twins studies found a strong heritability (strong genetic factors) but genetic studies such association studies of large cohorts of patient (GWAS or Genome Wide Association Study) have elucidated less than 20 % of the genetic basis of JIA. The vision of the genetics of multifactorial diseases has recently changed revealing a large clinical and genetic heterogeneity of these diseases. Indeed, the advent of next-generation sequencing identified non-multifactorial genetic hereditary disease related to mutations in genes having strong effect on the onset of the disease without real impact of environmental factors among the so called multifactorial diseases (Parkinson's, diabetes, osteoarthritis, Alzheimer's, hypertension ...)The investigators propose to study 30 families with several forms of JIA by next-generation sequencing. Identifying the genetic basis of JIA in these families will help to better understand the physiopathology of this disease and may help to the identification of novel therapeutic targets for other patients with JIA.

Official Title
-----------------
Identification of Genes Involved in Juvenile Idiopathic Arthritis by Wholel Exome Sequencing

Conditions
-----------------
Arthritis, Juvenile Rheumatoid

Intervention / Treatment
-----------------
* Biological: Blood sample


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: AJI oligoarticular form <4 joints AJI Polyarticular form> 4 joints AJI Forms systemic arthritis duration For more than six weeks Onset of symptoms before the age of 16 years Or rheumatoid factor or ANA + or CCP +Acceptation of both parenth to participate to the research and to perfom blood samples for genetic studies Exclusion Criteria: The (the) patient (e) is under tutorship or curatorship The (the) patient (e) is under judicial protection The (the) patient (e), or his parents, refuses to sign the consent It is impossible to give (the) patient (e) information lit JIA spondyloarthropathies such JIA type psoriatic arthritis or enthesopathy JIA not classifiable

Ages Eligible for Study
-----------------
Minimum Age: 1 Month
Maximum Age: 40 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Diagnostic
Intervention Model: Single Group Assignment
Masking: None (Open Label)


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Other: Juvenile idiopathic arthritis.<br>Blood sample | Biological: Blood sample<br>* Blood sample<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Identification of new genes by Next Generation Squencing (NGS) | Identification of new genes by Next Generation Squencing (NGS) in order to propose a new classification for prognosis and therapeutic orientation | 1 day | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Juvenile idiopathic arhtritis, JIA, Gene identification, Whole exome sequencing, Next generation sequencing, Identification of molecular basis, Acceptation of both parents to participate to the study